Scholar Rock Holding Corporation
A biopharmaceutical company working to develop human monoclonal antibodies that block the activity of myostatin in skeletal muscle to treat diseases caused by protein growth factor signaling. The company is developing therapies for neuromuscular diseases such as spinal muscular atrophy, as well as cancer and fibrotic diseases. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 150 |
Founded | 2012 |
Financials | |
|---|---|
Market Capitalization | 725.76M |
Revenue | |
Operating Income | -189.21M |
Operating Margin | |
Net Income | -183.26M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 5061 / 5373 |
Sector : Healthcare | 1017 / 1144 |
Industry : Biotechnology | 555 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2695 / 5565 |
Sector : Healthcare | 366 / 1182 |
Industry : Biotechnology | 155 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 5060 / 5436 |
Sector : Healthcare | 1035 / 1164 |
Industry : Biotechnology | 572 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3732 / 5330 |
Sector : Healthcare | 525 / 1174 |
Industry : Biotechnology | 183 / 667 |